I graduated from UC Berkeley in 2019 with a B.S. in Bioengineering. I have spent the last three years at PACT Pharma working on development of a personalized TCR-based cell therapy. I am interested in improving the efficacy of adoptive cell therapies in solid tumors. Some areas of particular interest include trafficking into the tumor mass and overcoming immunosuppression.